|
TIFA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.77395900588817E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63180580159406E-12 |
| Normal-vs-Stage2 |
1.23720000910765E-09 |
| Normal-vs-Stage3 |
5.44009282066327E-15 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
1.035200E-01 |
| Stage1-vs-Stage3 |
6.704000E-01 |
| Stage1-vs-Stage4 |
1.078470E-03 |
| Stage2-vs-Stage3 |
1.031150E-01 |
| Stage2-vs-Stage4 |
1.280650E-03 |
| Stage3-vs-Stage4 |
1.487500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62669877568078E-12 |
| Normal-vs-AfricanAmerican |
7.33500005178911E-09 |
| Normal-vs-Asian |
1.62525548574877E-12 |
| Caucasian-vs-AfricanAmerican |
9.158200E-01 |
| Caucasian-vs-Asian |
3.125800E-01 |
| AfricanAmerican-vs-Asian |
4.436800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1094237467878E-15 |
| Normal-vs-Female |
7.88258347483861E-15 |
| Male-vs-Female |
4.725800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62669877568078E-12 |
| Normal-vs-Age(41-60Yrs) |
5.6621374255883E-15 |
| Normal-vs-Age(61-80Yrs) |
1.72051262126161E-12 |
| Normal-vs-Age(81-100Yrs) |
4.39070000000097E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.607400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.576600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.968000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.494200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.981200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.930400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.929620E-02 |
| Classical-VS-Follicular |
2.461500E-03 |
| Classical-VS-Other |
7.242600E-01 |
| Classical-VS-Normal |
3.99680288865056E-15 |
| Tall-VS-Follicular |
3.8541000000003E-05 |
| Tall-VS-Other |
3.727000E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
4.952000E-01 |
| Follicular-VS-Normal |
2.12679873712318E-11 |
| Other-VS-Normal |
6.008300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97397653778353E-13 |
| Normal-vs-N1 |
1.62436730732907E-12 |
| N0-vs-N1 |
1.62360000000028E-07 |
|
|
